ES461980A1 - Un procedimiento para la preparacion de nuevos derivados delimidazol. - Google Patents

Un procedimiento para la preparacion de nuevos derivados delimidazol.

Info

Publication number
ES461980A1
ES461980A1 ES461980A ES461980A ES461980A1 ES 461980 A1 ES461980 A1 ES 461980A1 ES 461980 A ES461980 A ES 461980A ES 461980 A ES461980 A ES 461980A ES 461980 A1 ES461980 A1 ES 461980A1
Authority
ES
Spain
Prior art keywords
substituted
phenyl
derivatives
pharmaceutical activity
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461980A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES461980A1 publication Critical patent/ES461980A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Un procedimiento para la preparación de nuevos derivados del imidazol de fórmula: (Ver fórmula) donde cada uno de R1 y R2 es independientemente fenilo, fenilalquilo inferior de cadena recta o fenilalquenilo inferior de cadena recta; o uno de los anteriores sustituido en el anillo fenilo por uno o más sustituyentes seleccionados independientemente del grupo que consiste de alquilo inferior de 1 a 4 átomos de carbono, halo y trifluormetilo; X es oxígeno o azufre; n es un número de 1 a 8 con la condición de que n no es 1. Cuando R1 es fenilo o fenilo sustituido; o una sal de adición de ácido del mismo antimicrobiana cuyo procedimiento consiste en: a) hidrogenar un concepto de fórmula : (Ver fórmula) o una sal de adición de ácido del mismo, en donde R1', y R2' son idénticos a R1 y R2, respectivamente, como se definió para la fórmula (I), excepto que R1' y/o R2', contiene instauración olefínica alifática, y b) opcionalmente convertirla base libre a su sal de adición de ácido, oconvertir la sal de adición de ácido a la base libre correspondiente.
ES461980A 1975-07-28 1977-08-30 Un procedimiento para la preparacion de nuevos derivados delimidazol. Expired ES461980A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59961875A 1975-07-28 1975-07-28
US66502376A 1976-03-08 1976-03-08

Publications (1)

Publication Number Publication Date
ES461980A1 true ES461980A1 (es) 1978-06-01

Family

ID=27083399

Family Applications (2)

Application Number Title Priority Date Filing Date
ES461980A Expired ES461980A1 (es) 1975-07-28 1977-08-30 Un procedimiento para la preparacion de nuevos derivados delimidazol.
ES461979A Expired ES461979A1 (es) 1975-07-28 1977-08-30 Un procedimiento para la preparacion de nuevos derivados delimidazol.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES461979A Expired ES461979A1 (es) 1975-07-28 1977-08-30 Un procedimiento para la preparacion de nuevos derivados delimidazol.

Country Status (14)

Country Link
JP (1) JPS6028820B2 (es)
AU (1) AU505298B2 (es)
CH (2) CH621117A5 (es)
DE (1) DE2633492A1 (es)
ES (2) ES461980A1 (es)
FR (1) FR2319348A1 (es)
GB (1) GB1522717A (es)
HK (1) HK8480A (es)
IE (1) IE43409B1 (es)
MX (1) MX3866E (es)
MY (1) MY8000271A (es)
NL (1) NL183760C (es)
NZ (1) NZ181567A (es)
PH (1) PH14563A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1567431A (en) * 1977-01-10 1980-05-14 Syntex Inc 1-(2-(halophenylthio)-4-(p-chloro- or-flrorophenyl)-n-butyl) imidazoles
US4213991A (en) * 1978-05-30 1980-07-22 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles and compositions and methods containing the same
DE2845254A1 (de) * 1978-10-18 1980-05-08 Basf Ag Gamma -azolylverbindungen
DE2963796D1 (en) * 1979-01-22 1982-11-11 Syntex Inc Imidazole derivatives, pharmaceutical compositions containing them and their preparation
DE2912288A1 (de) * 1979-03-28 1980-10-09 Bayer Ag Verfahren zur herstellung von hydroxyethyl-azolen
JPS55160767A (en) * 1979-05-31 1980-12-13 Idota Yutaka Imidazole derivative
CA1155853A (en) * 1980-06-06 1983-10-25 Joseph A. Martin Imidazole derivatives and preparation thereof
EP0105575B1 (en) * 1982-07-12 1987-03-04 G.D. Searle & Co. 1-(1h-imidazolyl), 1-n-morpholinyl and pyridyl compounds, their preparation and pharmaceutical compositions containing them
JPS6068220A (ja) * 1983-09-24 1985-04-18 株式会社マキ製作所 フル−ツキヤツプの自動装着方法と装置
JPH0829011B2 (ja) * 1987-11-16 1996-03-27 井関農機株式会社 苗移植機
JPH03115267A (ja) * 1989-09-28 1991-05-16 Maruho Kk プロピオフエノン誘導体、その製造方法、それを含む中枢性筋弛緩剤および抗痙攣剤
JP6229896B2 (ja) * 2013-01-21 2017-11-15 国立大学法人大阪大学 フェノキシアルキルアミン化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
US3658813A (en) * 1970-01-13 1972-04-25 Janssen Pharmaceutica Nv 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate

Also Published As

Publication number Publication date
CH621117A5 (en) 1981-01-15
HK8480A (en) 1980-03-14
JPS6028820B2 (ja) 1985-07-06
FR2319348B1 (es) 1979-07-13
DE2633492C2 (es) 1990-10-25
FR2319348A1 (fr) 1977-02-25
ES461979A1 (es) 1978-12-01
NL183760B (nl) 1988-08-16
AU505298B2 (en) 1979-11-15
IE43409L (en) 1977-01-28
AU1622276A (en) 1978-02-02
DE2633492A1 (de) 1977-02-24
GB1522717A (en) 1978-08-23
NZ181567A (en) 1978-04-28
MY8000271A (en) 1980-12-31
NL7608297A (nl) 1977-02-01
IE43409B1 (en) 1981-02-25
CH623040A5 (en) 1981-05-15
MX3866E (es) 1981-08-26
JPS5217472A (en) 1977-02-09
NL183760C (nl) 1989-01-16
PH14563A (en) 1981-09-24

Similar Documents

Publication Publication Date Title
DE3069633D1 (en) Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
ES461979A1 (es) Un procedimiento para la preparacion de nuevos derivados delimidazol.
ES462065A1 (es) Procedimiento para la preparacion de derivados de tiazolidi-na.
GB1427112A (en) Antifouling compositions
ES8304117A1 (es) "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".
ES460286A1 (es) Un procedimiento de preparacion de espiro(1,3-dioxolan-4,3) quinuclidina.
ES457993A1 (es) Un procedimiento para la preparacion de una isotiazolopiri- dina.
SE7411243L (es)
IL72517A0 (en) Antibiotic,its production and compositions containing it
ES446187A1 (es) Un metodo de preparar nuevos compuestos de oxima-eter.
ES8104247A1 (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden- hidracionopiridacina
ES481271A1 (es) Procedimiento de preparacion de derivados de la l-cisteina.
GB1299566A (en) Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
ES413851A1 (es) Un metodo de obtencion de compuestos de tioureidobenceno.
ES450211A1 (es) Procedimiento para la obtencion de nuevos derivados de la 1-hidroxi-benzo-2,3,1-diazaborina.
GB1279547A (en) N-arylidene derivatives of erythromycylamine
ES416816A1 (es) Un procedimiento para la preparacion de triazolobenzodiace-pinas.
ES438717A1 (es) Procedimiento para preparar (1-imidazolil)-(1))(2-4-4- clo- rofenil) fenoxil)-4, 4-dimetil-pentan-3-ona.
ES440905A1 (es) Un procedimiento para la preparacion de una composicion her-bicida.
ES439982A1 (es) Procedimiento para la preparacion de nuevos 2-tetrmetodo de colocar y embalar cuerpos esfericos en cahidrofu- ril-6, 7-benzomorfanos disustituidos en ajas. 5, 9-beta.
ES334879A2 (es) Procedimiento para la preparacion de una amidina o una sal de adicion de acido correspondiente.
GB975924A (en) N-heterocyclic 2,6-dialkylbenzoic acid esters
ES375526A1 (es) Un procedimiento para la preparacion de compuestos amino- carbonilalquilicos n,n-disustituidos.
ES402749A1 (es) Un procedimiento para la preparacion de derivados de tieno-diacepina.
ES361430A1 (es) Procedimiento para la preparacion de compuestos efectivos en el tratamiento de condiciones broncoespasticas.